DCM
ACAD icon

Davis Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Davis Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177 Buy
+7
New +$154 ﹤0.01% 879

Other funds holding ACAD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Davis Capital Management's ACAD Position: Q2 2026 in Review

Davis Capital Management opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 7 shares worth $177. The stake represents ﹤0.01% of the portfolio and ranks #879 among its holdings.

53 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Davis Capital Management held 7 shares of Acadia Pharmaceuticals worth $177 as of Q2 2026.
  • Acadia Pharmaceuticals was a new Davis Capital Management position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #879 holding.
  • 53 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.